Financing ·
DNA X, Inc. entered into a securities purchase agreement with DNA Holdings Venture, Inc. on June 29, 2026, to issue…
SONMDNA X, Inc.
DNA X, Inc. entered into a securities purchase agreement with DNA Holdings Venture, Inc. on June 29, 2026, to issue 1,346,531 shares of non-voting Series B Convertible Preferred Stock at $6.00 per share for an aggregate price of $8.1 million. The transaction includes $5.0 million in cash and the cancellation of a $3.1 million convertible promissory note. DNA X, Inc. operates in the technology sector and develops the DNA-X platform.